Skip to content
中文产业新闻精选评分84Chinese source

恒瑞瑞康曲妥珠单抗获批新适应症,为结直肠癌领域首款获批ADC

结直肠癌领域首个!恒瑞HER2 ADC获批新适应症

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.